Insider trading

Period: 120 months Stock: TVRD + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

173 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

173 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

173 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

173 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
173 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
173 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

173 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Feb 2025
Posner Christopher PRESIDENT AND CEO
Sold at will
$2.77K 583 at 4.75
4.3%
Not planned
28 Feb 2025
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
$775.88 163 at 4.76
2.2%
Not planned
4 Feb 2025
Posner Christopher PRESIDENT AND CEO
Sold at will
$1.76K 372 at 4.72
2.6%
Not planned
4 Nov 2024
Posner Christopher PRESIDENT AND CEO
Sold at will
$1.06K 3,668 at 0.29
2.1%
Not planned
1 Aug 2024
Posner Christopher PRESIDENT AND CEO
Sold at will
$1.45K 4,149 at 0.35
2.3%
Not planned
2 May 2024
Posner Christopher PRESIDENT AND CEO
Sold at will
$2.95K 3,936 at 0.75
2.2%
Not planned
5 Apr 2024
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
$2.28K 2,753 at 0.83
3.0%
Not planned
5 Apr 2024
Goncalves Joana CHIEF MEDICAL OFFICER
Sold at will
$2.28K 2,753 at 0.83
4.9%
Not planned
29 Feb 2024
Posner Christopher PRESIDENT AND CEO
Sold at will
$5.19K 5,834 at 0.89
3.1%
Not planned
29 Feb 2024
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
$2.93K 3,293 at 0.89
3.5%
Not planned
29 Feb 2024
Goncalves Joana CHIEF MEDICAL OFFICER
Sold at will
$2.93K 3,293 at 0.89
5.5%
Not planned
8 Feb 2024
Posner Christopher PRESIDENT AND CEO
Sold at will
$18.85K 35,575 at 0.53
16.0%
Not planned
1 Feb 2024
Posner Christopher PRESIDENT AND CEO
Sold at will
$2.74K 4,981 at 0.55
2.2%
Not planned
2 Nov 2023
Posner Christopher President and CEO
Sold at will
$4.63K 3,796 at 1.22
2.3%
Not planned
3 Aug 2023
Posner Christopher President and CEO
Sold on a plan
$13.22K 4,307 at 3.07
2.5%
Planned (10b5-1)
23 Jun 2023
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold on a plan
$10.51K 2,993 at 3.51
1.9%
Planned (10b5-1)
23 Jun 2023
Goncalves Joana Chief Medical Officer
Sold on a plan
$9.56K 2,723 at 3.51
4.8%
Planned (10b5-1)
23 Jun 2023
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold on a plan
$8.72K 2,483 at 3.51
2.7%
Planned (10b5-1)
5 May 2023
Posner Christopher President and CEO
Sold on a plan
$17.02K 3,869 at 4.40
2.2%
Planned (10b5-1)
4 Apr 2023
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold at will
$13.42K 2,733 at 4.91
1.7%
Not planned
4 Apr 2023
Goncalves Joana Chief Medical Officer
Sold at will
$12.18K 2,481 at 4.91
4.2%
Not planned
4 Apr 2023
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold at will
$12.18K 2,481 at 4.91
2.7%
Not planned
3 Mar 2023
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$66.05K 6,802 at 9.71
4.1%
3 Mar 2023
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$60.75K 6,256 at 9.71
6.3%
3 Mar 2023
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$60.41K 6,221 at 9.71
9.6%
3 Mar 2023
Posner Christopher President and CEO
Sold, plan not stated
$58.13K 5,987 at 9.71
3.3%
16 Feb 2023
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$23.10K 2,265 at 10.20
3.4%
8 Feb 2023
Goncalves Joana CHIEF MEDICAL OFFICER
Sold at will
$4.12K 7,770 at 0.53
11.6%
Not planned
8 Feb 2023
Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.
Sold at will
$4.12K 7,770 at 0.53
7.6%
Not planned
8 Feb 2023
Maynard Ryan D CHIEF FINANCIAL OFFICER
Sold on a plan
$2.91K 5,488 at 0.53
40.7%
Planned (10b5-1)
2 Feb 2023
Posner Christopher President and CEO
Sold, plan not stated
$49.45K 4,191 at 11.80
2.2%
17 Jan 2023
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$24.48K 2,265 at 10.81
3.3%
29 Dec 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$23.06K 2,265 at 10.18
3.2%
21 Dec 2022
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$39.51K 3,506 at 11.27
2.1%
21 Dec 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$33.72K 2,992 at 11.27
4.0%
21 Dec 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$28.86K 2,561 at 11.27
2.5%
16 Nov 2022
Posner Christopher President and CEO
Sold, plan not stated
$161.05K 14,470 at 11.13
7.2%
14 Sep 2022
VOGELBAUM MARTIN Director
Sold, plan not stated
$111.02K 10,800 at 10.28
19.4%
15 Jul 2022
Sold, plan not stated
$65.16K 7,200 at 9.05
22.3%
15 Jul 2022
Ives Jeffrey L. Director
Sold, plan not stated
$32.58K 3,600 at 9.05
18.9%
4 Apr 2022
Posner Christopher President and CEO
Sold, plan not stated
$25.42K 2,006 at 12.67
1.0%
1 Apr 2022
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$21.25K 1,784 at 11.91
1.0%
1 Apr 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$19.56K 1,642 at 11.91
2.1%
1 Apr 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$19.56K 1,642 at 11.91
1.6%
3 Mar 2022
Reilly Thomas Charles Chief Financial Officer
Sold, plan not stated
$23.26K 2,044 at 11.38
5.1%
3 Mar 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$20.34K 1,787 at 11.38
1.7%
25 Feb 2022
Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D
Sold, plan not stated
$21.75K 2,114 at 10.29
1.2%
25 Feb 2022
Goncalves Joana Chief Medical Officer
Sold, plan not stated
$20.29K 1,972 at 10.29
2.5%
25 Feb 2022
Terrillion Scott Sec'y; Chief Compliance & G.C.
Sold, plan not stated
$20.29K 1,972 at 10.29
1.9%
12 Nov 2021
Ives Jeffrey L. Director
Sold, plan not stated
$131.21K 8,180 at 16.04
53.2%
Sold half or more
Showing 1–50 of 173. Page 1 of 4 Older →